Divamics home

DIVANICS news

Let's talk

2024. 05.25

New cooperation

LIDE and Divamics have entered into a strategic partnership to accelerate the integration of “BT + IT” and empower new drug development

LIDE and Divamics have entered into a strategic partnership to accelerate the integration of “BT + IT” and empower new drug development

POSTED BY DIVAMICS ON 29 February, 2024

LIDE and Divamics held a strategic cooperation project kick-off meeting at LIDE， for accelerating the integration of “BT + IT” and empowering new drug research and development. The strategic cooperation agreement was signed by Danyi Wen,n, PhD, Chairman and CEO of LIDE and John Zheng, PhD, the CEO of Dicamics.

LIDE and Divamics have entered into a strategic partnership to accelerate the integration of “BT + IT” and empower new drug development

POSTED BY DIVAMICS ON 17 August, 2023

G protein-coupled receptors (GPCRs) are the largest family of receptors in cell membranes, and GPCRs play key roles in a variety of signaling pathways inside and outside the cell. They trigger complex intracellular signaling cascades upon recognition of external molecules (e.g., hormones, neurotransmitters, drugs, etc.) that regulate physiological processes such as growth, development, and metabolism in the body.

Copyright © 2023 Divamics Inc. |

Phone：+86 18811507996

E-mail：bd@szdeepdynamics.com

Address: 11-301 Creative Industry Park, Suzhou Industrial Park, Suzhou City, Jiangsu Province

Scan and Follow us

by WeChat

Dynamic Virtual Filtering

Target Mechanism Exploration of Difficult to Prepare Drugs

Support:

Company Profile

苏ICP备2023018134号

Design and Structural Optimization of Small Molecule Drugs

Design and Structural Optimization of Protac Drug

Dynamic Simulation of

Biological Macromolecular Systems